- Home
- Latest
- By speciality
- Policy
- Biology
- Bone
- Brain and nervous system
- Breast
- Colorectal and gastrointestinal
- Community
- Diagnostics
- Drug development
- Epidemiology and prevention
- Haematology oncology
- Head and neck
- Hepatobiliary pancreatic
- Lung and pleura
- Melanoma and skin
- Ovary and gynaecology
- Paediatric
- Prostate and urology
- Psycho social
- Radiotherapy
- Sarcomas
- Surgery
- Other
- By congress
- By continent
- Latest technologies
- Education
- Most viewed
- View all
Breast, Cell therapy, Drug development, IMPAKT, North America
Flash player required
You do not have the correct version of the flash player required to view this content. Click here to install the free Adobe flash player.
Dr Joanne Zujewski - Head of Breast Cancer Therapeutics, NCI, USA
Personalised breast cancer therapy and the ALLTO trial
Dr Joanne Zujewski, Head of Breast Cancer Therapeutics at the National Cancer Institute, USA, talks to ecancer at the 1st IMPAKT meeting about the BIG group, ALLTO trial, personalised medicine and coordinating cross-atlantic research.
Specialities
- Policy (10)
- Biology (62)
- Bone (24)
- Brain and nervous system (14)
- Breast (190)
- Colorectal and gastrointestinal (43)
- Community (83)
- Diagnostics (37)
- Drug development (85)
- Epidemiology and prevention (53)
- Haematology oncology (60)
- Head and neck (17)
- Hepatobiliary pancreatic (17)
- Lung and pleura (47)
- Melanoma and skin (27)
- Ovary and gynaecology (33)
- Paediatric (17)
- Prostate and urology (42)
- Psycho social (19)
- Radiotherapy (27)
- Sarcomas (15)
Content is the view and comment of the speakers or author and not of sponsoring companies or organisations. Organisation logo does not indicate endorsement.
Comments on this video Report unsuitable comment
No comments have been made on this video yet, be the first to voice your opinion, use the form on the right.
Add a comment